Ethan J. Mueller

Ethan J. Mueller serves as a Contract Specialist and Contracting Officer responsible for managing the full lifecycle of federal acquisitions, from requirements definition and market research to contract award and administration. He plays a pivotal role in ensuring compliance with federal procurement regulations while advancing mission-critical objectives through strategic sourcing. His portfolio primarily encompasses complex scientific and pharmaceutical procurement actions, requiring deep technical understanding and rigorous risk mitigation practices. Mueller routinely handles competitive sealed bids, negotiated procurements, and task order contracts under FAR and agency-specific guidelines, emphasizing transparency, fairness, and value-driven outcomes. While no specific contractor relationships are identified in available data, Mueller’s procurement patterns suggest engagement with a broad spectrum of vendors, including established biotechnology firms and wholesale distributors of pharmaceutical products. His approach favors open competition and performance-based contracting, fostering partnerships with firms capable of delivering high-compliance, high-integrity solutions in regulated environments. He maintains a neutral stance toward vendor size or certification status, prioritizing technical capability, past performance, and regulatory adherence in source selection. Mueller’s contracting activity is entirely non-set-aside, with 100% of awards issued under full and open competition. This reflects a deliberate procurement strategy aligned with mission requirements that demand specialized expertise, broad market capacity, or rapid scalability—conditions where socioeconomic set-asides may not be feasible or appropriate. His approach underscores a commitment to merit-based selection while maintaining full compliance with statutory obligations under the Small Business Act. His primary procurement focus lies in NAICS 541714 (Research and Development in Biotechnology), indicating deep involvement in early-stage drug discovery, clinical trial support, and laboratory innovation services. Secondary activity in NAICS 424210 (Drugs and Druggists’ Sundries Merchant Wholesalers) suggests coordination of supply chain logistics for pharmaceuticals and medical bulk inputs. Mueller’s expertise spans biopharmaceutical R&D, regulatory compliance, and cold-chain logistics, positioning him as a key technical buyer in the life sciences procurement ecosystem.